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Purpose. To show how peripapillary spectral domain optical coherence tomography (SDOCT) retinal thickness (RT) maps can
complement retinal nerve fiber layer (RNFL) thickness maps in the evaluation of glaucoma patients. Methods. After a complete eye
examwith standard fundus photography and visual field testing, normal and glaucomatous eyes were imaged with an experimental
SDOCT system. From SDOCT images, RNFL thickness and RT maps were constructed and then correlated with disc photography
and visual field testing. Results. Two normal eyes of 2 patients and 5 eyes of 4 glaucoma patients were imaged. Although both RNFL
and RT maps correlated well with visual field defects, glaucomatous arcuate defects were sometimes more easily identified in the
RTmaps. Conclusions. To our knowledge, this is the first paper to show that peripapillary SDOCT RTmaps may provide important
supplemental information to RNFL thickness maps in the evaluation of glaucoma patients.
1. Introduction
Although glaucoma is primarily a disease of the ganglion
cells, the retinal nerve fiber layer (RNFL) is the most com-
monly imaged layer of the retina in the evaluation of glau-
coma patients. Even before the widespread use of imaging
technologies, RNFL evaluation has always been an important
part of the clinical examination of glaucoma patients [1, 2].
Unlike the ganglion cell layer or other neurosensory retinal
layers which are relatively optically transparent, the RNFL is
more readily seen on a standard clinical exam and shows fine
striations with ophthalmoscopy or slit lamp biomicroscopy
with or without a red-free light source. Glaucomatous RNFL
changes with red-free photography can even be visualized as
early as 6 years prior to glaucomatous visual field defects [1–
3].
With ultrahigh acquisition speeds and ultrahigh resolu-
tion capabilities [4–6], spectral domain optical coherence
tomography (SDOCT) technology can image large areas
around the optic nerve head and can potentially provide
the most comprehensive quantitative evaluation of the RNFL
and retina in glaucoma [5]. In contrast to time domain
optical coherence tomography (OCT) which only measures
RNFL thickness along a circular scan centered on the optic
nerve head, SDOCT can create RNFL thickness maps of large
areas around the optic nerve head (e.g., 5× 5mm areas) [7].
A limitation of OCT RNFL thickness measurements is
that RNFL thickness measurements are less reliable when
the RNFL is thinned, as occurs with glaucoma [8]. In a
study of the reliability of RNFL thickness measurements
with time domain OCT (StratusOCT, Carl Zeiss Meditec,
Dublin, Calif), the coeﬃcients of variation were higher in
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glaucomatous patients than in normal patients for all the test
parameters [9]. Because of the inherent diﬃculties in obtain-
ing reliable RNFL thickness maps in glaucoma patients, this
study investigated whether supplemental SDOCT peripapil-
lary retinal thickness (RT) maps, which are easier to obtain,
can also be correlated with fundus photography and visual
field testing and whether RT maps may potentially be useful
in the clinical evaluation of normal and glaucoma patients.
To our knowledge, this is the first publication to suggest
the use of peripapillary RT maps in the evaluation of glau-
coma patients. After a PubMed search, we are also unaware
of any previous publications correlating peripapillary retinal
thickness maps with disc photography and visual field testing
in glaucoma patients.
2. Methods
This research adhered to the tenets of the Declaration
of Helsinki. Study protocols were approved by the Mas-
sachusetts Eye and Ear Infirmary and Massachusetts General
Hospital Institutional Review Boards and were in accordance
with the Health Insurance Portability and Accountability
Act [10]. All volunteers signed informed consents prior to
enrollment in the study. Any eyes with retinal or optic nerve
diseases other than glaucoma were excluded.
All volunteers had a complete eye exam which con-
sisted of best-corrected visual acuity, Goldmann applanation
tonometry, slit lamp examination, gonioscopy, and fundus
examination by a glaucoma specialist (TC). All volunteers
were imaged with fundus photography (Topcon TRC 50IX
fundus camera (Topcon, Tokyo, Japan) or Visucam Pro NM
(Carl Zeiss Meditec, Dublin, Calif)), had visual field testing
using the SITA-standard 24-2 program of the Humphrey
visual field analyzer 750i (Carl Zeiss Meditec, Dublin, Calif),
and underwent SDOCT imaging.
Patients were defined as having glaucoma if they had
(1) characteristic glaucomatous visual field changes and
(2) optic nerve head changes characteristic for glaucoma,
as defined below. Optic disc abnormalities included one
or more of the following: excavation, notching, focal, or
diﬀuse atrophy of neuroretinal rim area, cup-disc asymmetry
between fellow eyes greater than 0.2, or disc hemorrhage.
Excavation was defined as undermining of the neuroretinal
rim; notching was considered if it involved 2 clock hours;
atrophy was defined as neuroretinal rim thinning involving 2
or more clock hours. These eligibility criteria were modeled
after the Advanced Glaucoma Intervention Study (AGIS)
criteria for open-angle glaucoma (Table 1 from Controlled
Clinical Trials 1994; 15:299–325) [11]. Primary open-
angle glaucoma, normal-tension glaucoma, pseudoexfolia-
tion glaucoma, and chronic angle closure glaucoma patients
were included. Chronic angle-closure glaucoma patients had
to have at least half of the angle closed by gonioscopy.
Physiologic cupping was diagnosed when patients had
eye pressures under 22mmHg, vertical cup-disc ratios
greater than 0.4, and normal visual field testing. All normal
eyes had normal-appearing optic nerves, had normal visual
field testing, had refractive errors of less than ±5 diopters,
Table 1: Demographics and diagnoses of the 7 eyes of 6 patients
who had spectral domain optical coherence tomography imaging
of the peripapillary retina and peripapillary retinal nerve fiber layer.
Eye
number
Gender/age
(years)
Eye Diagnosis
1 F/52 OD Normal
2 M/41 OD Physiologic cupping
3 M/36 OD Normal-tension glaucoma
4 F/81 OD Open-angle glaucoma
5 F/81 OS Open-angle glaucoma
6 F/73 OD Pseudoexfoliation glaucoma
7 F/83 OD Open-angle glaucoma
M: male, F: female, OD: right eye, and OS: left eye.
and were never documented to have intraocular pressures
higher than 21mm Hg.
The experimental SDOCT instrument was developed
at the Massachusetts General Hospital, Wellman Center
for Photomedicine. The basic setup has been published
previously in detail [7, 12]. For the light source, a superlu-
minescent diode (SLD, Superlum, Russia) with a full width
at half maximum (FWHM) spectral width of 50 nm centered
at 840 nm was used. The SDOCT data were processed using
an algorithm which measured both the RNFL thickness and
the RT [7, 12, 13]. The algorithm sequentially finds the top
surface of the retina, then the posterior boundary of the
retinal pigment epithelium (RPE), and then the posterior
boundary of the RNFL. The largest intensity gradient is
automatically found at each step of the program. The
segmentation algorithm used anisotropic noise filtering and
deformable contours to identify continuous boundaries of
interest. The depth diﬀerence between the top surface and the
posterior RNFL boundary gives the RNFL thickness, while
the diﬀerence between the top surface and the posterior
RPE boundary gives the RT. Figure 1 shows an example of
a typical SDOCT frame illustrating the three boundaries:
the top surface of the retina, the posterior RNFL, and the
posterior RPE as estimated by our automatic algorithm.
Scans of poor quality were excluded from this study. Poor
scan quality included either patient inability to complete
scanning of the entire optic nerve head region or physician
verification of inaccurate automated RNFL or RT boundary
determinations due to poor signal strength.
3. Results
Seven eyes of 6 patients were enrolled for this study. They
were two males and five females with mean age of 61.0 years
±20.7 standard deviations (range 36–83). The demographics
and diagnoses of the subjects are listed in Table 1.
Figure 2 shows the results of the seven eyes. The first
column shows the fundus photos. The second column shows
visual field testing. The last two columns represent the RT
maps and the RNFL thickness maps, respectively. The range
of the thickness scale is 0 to 500 microns for the RTmaps and
0 to 180 microns for the RNFL thickness maps (Figure 2).
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Figure 1: Example of a spectral domain optical coherence tomog-
raphy (SDOCT) frame that depicts the three boundaries that were
automatically determined by our algorithm: (1) top surface of the
retina, (2) the posterior retinal nerve fiber layer (RNFL), and (3)
the posterior retinal pigment epithelium (RPE). The algorithm
sequentially finds the top surface of the retina, the posterior
RPE boundary, and then the posterior RNFL boundary. The
depth diﬀerence between the top surface and the posterior RNFL
boundary gives the RNFL thickness while the diﬀerence between
the top surface and the posterior RPE boundary gives the retinal
thickness (RT). The lateral dimension of this frame is 5.81mm with
a scan depth of 1.85mm. The image was expanded vertically by 2
for better visualization.
The first eye is normal and shows maps consistent with
known normal anatomy in that the retina and RNFL are both
thicker superiorly and inferiorly (Figure 2). Eye number 2
has a larger cup but still has a normal visual field (VF). Both
RT and RNFL thickness maps appear normal. Eye number 3
with normal tension glaucoma has a superior nasal step on
VF testing. In eye number 3, the RNFL thickness map shows
more RNFL thinning inferiorly than superiorly, which also
correlates with the VF defect. In the disc photo, thinning
of the inferotemporal neuroretinal rim correlates well with
both the superior nasal VF defect and the inferotemporal
RNFL thinning. The 4th eye shows an inferior arcuate
scotoma on VF testing. In this eye, the RT map clearly
shows an arcuate area of superior retinal thinning (arrow)
which correlates well with the inferior arcuate VF defect.
In eye number 4, the arcuate nature of the RNFL defect is
not as clearly seen in the RNFL thickness map. In the disc
photo, the superotemporal notch with associated superior
neuroretinal rim thinning correlates well with the inferior
arcuate VF scotoma. Eye number 5 shows a dense superior
arcuate with an inferior paracentral defect and an inferior
nasal step. The RT map shows a diﬀusely thinned retina,
although with perhaps more thinning inferiorly. The RNFL
thickness map also shows diﬀuse thinning with perhaps
more RNFL thinning inferiorly. The 6th eye shows an
inferior nasal step and an inferior paracentral scotoma. Both
the RT and RNFL thickness maps show greater retinal and
RNFL thinning superiorly. Eye number 7 shows vertical
cupping with greater thinning of the inferior neuroretinal
rim on disc photography, which correlates well with the
superior nasal step on VF testing. This superior nasal step
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Figure 2: Spectral domain optical coherence tomography
(SDOCT) retinal thickness (RT) and retinal nerve fiber layer
(RNFL) thickness peripapillary maps in normal (no. 1-2) and
glaucoma (no. 3–7) patients. First column: disc photos, second
column: visual fields, third column: RT maps, and fourth column:
RNFL thickness maps. The thickness scales are seen as the bottom
two color bars. The RT map scale ranges from 0 to 500 microns,
and the RNFL thickness scale ranges from 0 to 180 microns.
Visualization of classic glaucomatous arcuate defects is better seen
in RT maps (arrows) than RNFL maps for eyes numbered 4 and 7.
also correlates well with the inferior arcuate retinal thinning
seen on the RT map (arrow). The RNFL thickness map less
clearly shows inferior arcuate RNFL thinning.
4. Discussion
Retinal nerve fiber layer evaluation is a classic part of the
evaluation of a glaucoma patient, and imaging devices have
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been developed to measure RNFL thickness values which can
be correlated with visual function [14–17]. RNFL imaging
also provides a more objective quantitative evaluation of the
RNFL than both the subjective clinical exam and qualitative
red-free photography [7]. Imaging devices which calculate
RNFL thickness values include the following: scanning laser
polarimetry (SLP, GDxVCC, Carl Zeiss Meditec, Dublin,
Calif), confocal scanning laser ophthalmoscopy (HRT, Hei-
delberg Retina Tomograph, Heidelberg Engineering, Heidel-
berg, Germany), and OCT. SLP however only measures the
RNFL thickness indirectly [15, 18–20]. Confocal scanning
laser ophthalmoscopy also does not determine true RNFL
values, because HRT RNFL thickness values are calculated
retinal surface heights from a fixed reference plane 50
microns below the temporal surface of the retina [4]. Of these
three imaging technologies, OCT is the only imaging device
that measures the RNFL thickness directly [4, 16, 17, 21].
Although OCT is the only technology that directly mea-
sures the RNFL thickness, accurate peripapillary RNFL thick-
ness measurements in glaucoma patients are often diﬃcult
to obtain for a few reasons. OCT RNFL thickness measure-
ments are sometimes less reliable in glaucoma patients [7–
9], because decreased RNFL reflectivity, which is associated
with glaucomatous damage, makes the posterior RNFL
boundary harder to distinguish from the less reflective
underlying cellular layers (i.e., the ganglion cell and inner
nuclear layers). Especially with the decreased RNFL reflec-
tivity seen in glaucoma, the contrast between the RNFL and
the ganglion cell layer/inner plexiform layer (GCL/IPL) is less
distinct compared to the contrast between the RPE and sur-
rounding layers. Because of the inherent problems with mea-
suring peripapillary RNFL thickness in glaucoma patients,
an alternative measurement of the peripapillary nerve tissue
that may be helpful in glaucoma evaluation is RT evalu-
ation. RT measurements have theoretical advantages over
RNFL measurements in glaucoma because, unlike the RNFL
posterior boundary which becomes less distinct with glau-
comatous change, the posterior boundary of the retina (i.e.,
the highly reflective RPE) is always distinct with even end-
stage glaucoma. Therefore, segmentation or identification of
this RPE boundary (i.e., posterior retina boundary) is con-
sistently more robust in glaucoma patients, making peripap-
illary RT determinations potentially more reliable than the
peripapillary RNFL thickness measurements. Also, in theory,
RT should still have clinical relevance in that thinned RNFL
areas should still correspond to areas of thinner RT. Lastly,
despite SDOCT’s improved resolutions (i.e., about 2 microns
for experimental machines) and shorter examination times
[5–7, 22–25], SDOCTRNFL thicknessmeasurements are still
subject to the inherent measurement variabilities of thinner
RNFLs with less reflectivity. In summary, in light of the
limitations of peripapillary RNFL thickness measurements
in glaucoma patients with both the time domain OCT and
SDOCT technologies, peripapillary RT maps may provide
more reliable information which is also consistently easier to
obtain.
With OCT imaging of glaucoma patients, RT and RNFL
thickness measurements are not usually both used for
analyzing the peripapillary region. In glaucoma evaluation,
RT measurements have focused on evaluating the macular
region of the retina [26–28], and RNFL thickness measure-
ments have usually been used to evaluate the peripapillary
retina. Evaluation of RT in the macular region in glaucoma
has been used since the macula is the area of the retina where
the ganglion cell layer is more than one cell layer thick, and
glaucoma has been associated with lower RT values in the
macula [27, 28]. SDOCT studies have also shown good
correlation of the macular ganglion cell complex with visual
field testing [29]. Although SDOCT allows for better 3-
dimensional imaging of the macular region [30], macular
imaging of the glaucoma patient may ultimately be limited
by nonglaucomatous macular pathology such as macular
degeneration or diabetes. In these patients with concomitant
macular disease, peripapillary RT measurements may be
more useful. Another advantage of peripapillary SDOCT RT
maps is that it includes the RNFL from the entire retina
(100%) compared to macular RT maps which image only
about 50% of the ganglion cells of the eye [28]. Therefore,
in the current SDOCT study, the peripapillary RT maps
include RNFL information from the entire retina (100%) as
well as the ganglion cell layer around the optic nerve head.
This study proposes that the most comprehensive evaluation
of glaucomatous structural changes in one region may be
achieved with SDOCT peripapillary RT and RNFL thickness
maps (Figure 2) of large areas of the posterior pole (e.g.,
6mm by 6mm area).
In this SDOCT study, we correlated structural changes in
peripapillary RT and RNFL thickness maps with functional
changes in visual field testing. For example, in eyes with
glaucoma (Figure 2, eyes numbered 3–7), both RT and RNFL
thickness maps showed that areas of superior nerve thinning
were associated with areas of inferior visual field loss. Also
in Figure 2, areas of inferior RT and RNFL thinning were
associated with areas of superior visual field loss. In eyes
numbered 4 and 7 (Figure 2), the RT maps more clearly
demonstrate typical glaucomatous arcuate defects (Figure 2,
arrows) compared to the RNFL thickness maps. These two
eyes in particular illustrate how RT maps can supplement
and complement RNFL thickness maps. The use of RT maps
for glaucoma evaluation also has basis in histology since
the total RT includes both the RNFL and the ganglion cell
layer, both layers which are aﬀected by glaucoma. Further
investigation is necessary to establish a normative database
for both RT and RNFL thickness maps. This would enable
better determination of glaucomatous changes compared to
age-matched normals.
RT measurements have certain limitations. Because it
includes all the retinal layers, any changes of any of these
layers by a nonglaucomatous disease process can aﬀect RT
maps. For example, diabetic changes or age-related macular
degeneration (AMD) can cause significant RT changes in the
macular region, which is why our current study focused on
RT maps around the optic nerve head. Like all informa-
tion from other imaging devices or from other subjective
diagnostic testing (e.g., visual field testing), RT maps should
be considered as supplemental information that ultimately
should be correlated with and be consistent with objective
clinical exam findings.
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In the patients with glaucoma (eyes numbered 3 through
7, Figure 2), the disc photos show that areas of neuroretinal
rim thinning correlate well with both VF testing and SDOCT
RT/RNFL thickness maps. Therefore, this study suggests that
there is good correlation between structure (i.e., optic nerve
head photos, RT/RNFL thickness maps) and function (i.e.,
visual field testing).
5. Conclusion
With SDOCT, both peripapillary RT maps and RNFL
thickness maps can be obtained and can correlate well with
neuroretinal rim thinning and visual field defects in glau-
coma patients. Even though this is a small case series, it shows
the novel concept of peripapillary RT maps that may be
another useful parameter for evaluating glaucoma patients,
especially when RNFL thickness maps are diﬃcult to inter-
pret or when RNFL thickness maps may be diﬃcult to obtain
due to glaucomatous RNFL changes. The use of RT maps
however is not meant to substitute for RNFL thickness maps
and also should be used with caution in the presence of con-
comitant diseases that aﬀect retinal layers deep to the RNFL.
Structure-function correlations between clinical exam find-
ings, quantitative SDOCT measurements, and visual field
testing need further investigation.
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